Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.3100
-0.0425 (-12.06%)
Jun 8, 2026, 2:54 PM EST
Avenue Therapeutics Revenue
Avenue Therapeutics had revenue of $1.40M in the twelve months ending March 31, 2026. In the year 2025, Avenue Therapeutics had annual revenue of $1.40M.
Revenue
1.40M
Revenue Growth
n/a
P/S Ratio
0.83
Revenue / Employee
1.40M
Employees
1
Market Cap
1.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.40M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAvenue Therapeutics News
- 4 weeks ago - Avenue Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Avenue Therapeutics Annual report: Q4 2025 - Filings
- 3 months ago - Avenue Therapeutics enters worldwide license agreement for ATX-04 - TheFly
- 5 months ago - Avenue Therapeutics Transcript: AGM 2025 - Transcripts
- 6 months ago - Avenue Therapeutics Proxy statement: Proxy Filing - Filings
- 7 months ago - Avenue Therapeutics Quarterly report: Q3 2025 - Filings
- 7 months ago - Avenue Therapeutics announces Baergic Bio acquisition by Axsome - TheFly
- 10 months ago - Avenue Therapeutics Quarterly report: Q2 2025 - Filings